D311 Final Exam: Key Study Questions on Microbial Pathogenesis

Student Name
Western Governors University
D311 Microbiology with Lab: A Fundamental Approach
Prof. Name
Date
D311 Specific Study Questions
Section 1
1) What is the difference between pathogenesis and virulence?
Pathogenesis describes the overall capability of a microorganism to cause disease. It involves the complex biological mechanisms and processes through which an infection develops and progresses in the host. In contrast, virulence specifically measures the degree of damage or severity caused by a pathogen during the infection. Essentially, pathogenesis explains the “how” behind disease development, while virulence quantifies the intensity or harmfulness of the symptoms produced.
2) What are the different types of virulence factors, and how do bacterial, viral, and eukaryotic factors differ?
Virulence factors are molecules or structures produced by pathogens that enable them to infect the host, evade immune defenses, and cause tissue damage. These factors vary significantly depending on the type of pathogen—bacteria, viruses, fungi, or helminths.
| Type of Pathogen | Virulence Factors | Examples and Description |
|---|---|---|
| Bacterial | Adhesion, evasion, invasion | Adhesion factors like Protein F in Streptococcus pyogenes facilitate attachment to respiratory cells causing strep throat. Evasion involves capsules and mycolic acid preventing phagocytosis. Invasion uses exoenzymes such as collagenase to degrade tissues. |
| Viral | Adhesion, immune evasion | Influenza virus uses hemagglutinin to bind respiratory cells. Viruses evade immune detection through antigenic drift (minor mutations) and antigenic shift (major genetic reassortment), altering surface proteins. |
| Fungal | Adhesins, capsules, mycotoxins | Candida albicans employs glycoproteins for adhesion and produces enzymes like keratinase for tissue invasion. Cryptococcus species have capsules that prevent phagocytosis. Some fungi, like Claviceps purpurea, produce toxins causing diseases. |
| Helminthic | Large size, protective cuticles, glycan mimicry | Large size makes phagocytosis difficult. Protective cuticles help resist immune damage. Glycan mimicry allows evasion by resembling host molecules, avoiding immune detection. |
3) How do endotoxins and exotoxins differ?
| Feature | Endotoxins | Exotoxins |
|---|---|---|
| Source | Produced only by Gram-negative bacteria; part of lipopolysaccharide (LPS) in outer membrane | Secreted proteins from both Gram-positive and Gram-negative bacteria |
| Effect | Cause systemic inflammatory responses such as fever and shock | Cause targeted cellular damage by binding specific receptors |
| Heat Stability | Heat stable | Mostly heat labile; some exceptions |
| Toxicity (LD50) | High dose required (less toxic) | Low dose required (highly toxic) |
Endotoxins typically provoke generalized immune reactions, including inflammation and fever, while exotoxins are highly potent and act specifically on certain cells or tissues.
4) How does the Gram stain differentiate between Gram-positive and Gram-negative bacteria?
Gram staining differentiates bacteria based on cell wall structure. Gram-positive bacteria have a thick peptidoglycan layer that retains the crystal violet-iodine complex, staining them purple. Gram-negative bacteria have a thinner peptidoglycan layer and an outer membrane; they lose the crystal violet during alcohol decolorization and absorb the counterstain safranin, appearing pink or red.
5) What are the differences between Acid-fast, Endospore, and Capsule staining?
| Staining Type | Purpose | Key Features |
|---|---|---|
| Acid-fast | Identify bacteria with waxy mycolic acid layers (e.g., Mycobacterium) | Acid-fast bacteria retain red carbolfuchsin dye; non-acid fast do not |
| Endospore | Differentiate bacterial endospores from vegetative cells | Endospores stain green with malachite green; vegetative cells stain red with safranin |
| Capsule | Visualize bacterial capsules | Negative staining; background stained dark, capsules appear as clear halos around cells |
6) What is a key difference between bacteria and protists?
Bacteria are prokaryotic organisms characterized by the absence of a membrane-bound nucleus and generally a single circular chromosome located in the nucleoid region. Protists, on the other hand, are eukaryotic cells with a defined nucleus and multiple linear chromosomes, reflecting a higher level of cellular complexity.
Section 2
1) How does commensalism differ from mutualism?
In mutualism, both organisms involved benefit from the interaction, often enhancing each other’s survival or growth. Commensalism describes a relationship where one organism benefits without affecting the other, which remains neutral or unaffected.
2) What distinguishes a noncommunicable infectious disease from a noninfectious disease?
Noncommunicable infectious diseases are caused by infectious agents but are not spread from person to person—for example, tetanus caused by Clostridium tetani. In contrast, noninfectious diseases are caused by non-microbial factors such as genetics, environmental influences, or immune dysfunction.
3) What is the difference between biological and mechanical vectors?
Mechanical vectors transmit pathogens passively by carrying them on their body surfaces (e.g., flies transferring bacteria on legs). Biological vectors harbor the pathogen internally, with the pathogen often undergoing development or multiplication before transmission, typically via biting (e.g., mosquitoes transmitting malaria).
4) How do vertical and horizontal direct contact transmission differ?
Vertical transmission occurs when pathogens are passed from mother to offspring during pregnancy, childbirth, or breastfeeding. Horizontal transmission involves direct contact between individuals outside of the maternal context, such as skin-to-skin contact or sexual transmission.
5) What differentiates a passive carrier from an active carrier?
A passive carrier transmits pathogens without being infected themselves, often through contaminated hands or surfaces (e.g., healthcare workers spreading bacteria). An active carrier is infected and can transmit the pathogen because they harbor the infectious agent.
6) How do the prodromal period and period of illness differ?
The prodromal period features early, nonspecific symptoms as the pathogen begins multiplying. The period of illness is marked by pronounced, characteristic symptoms, reflecting the peak of disease severity.
7) What differentiates the period of decline from the period of convalescence?
During the period of decline, symptoms and pathogen load decrease as the host immune system gains control. Convalescence is the recovery phase when the patient regains strength and returns to normal health, although some diseases may cause lasting damage.
8) What is the difference between morbidity rate and mortality rate?
| Rate | Definition |
|---|---|
| Morbidity rate | The number or proportion of individuals who become ill in a population |
| Mortality rate | The number or percentage of deaths caused by a disease in a population |
Section 3
1) When is an autoclave preferred for microbial control?
Autoclaves are the sterilization method of choice when complete eradication of all microorganisms, including bacterial spores, is necessary. This is especially important for surgical instruments and materials used in sterile procedures.
2) How does beta-lactamase contribute to antibiotic resistance?
Beta-lactamase enzymes hydrolyze the β-lactam ring in antibiotics like penicillins and cephalosporins, rendering these drugs ineffective. This enzymatic destruction is a major mechanism by which bacteria develop resistance to β-lactam antibiotics.
3) What are the differences between cellular and humoral immunity?
Humoral immunity is mediated by B cells producing antibodies that neutralize extracellular pathogens and toxins. Cellular immunity involves T cells that directly kill infected host cells or help orchestrate immune responses against intracellular pathogens.
4) How do the chickenpox and tetanus vaccines differ?
The chickenpox vaccine is a live attenuated vaccine that introduces a weakened form of the virus to stimulate immunity through a mild, subclinical infection. The tetanus vaccine is a toxoid vaccine containing inactivated toxins, which provoke antibody production without exposing the host to the whole pathogen.
5) What are examples of anti-helminthic drugs, and why are helminth infections difficult to treat?
Anti-helminthic drugs include niclosamide, praziquantel, and ivermectin. Helminth infections are challenging to treat because these parasites are complex multicellular eukaryotes, similar to their human hosts, making selective targeting without host toxicity difficult.
References
Madigan, M. T., Bender, K. S., Buckley, D. H., Sattley, W. M., & Stahl, D. A. (2018). Brock Biology of Microorganisms (15th ed.). Pearson.
Tortora, G. J., Funke, B. R., & Case, C. L. (2020). Microbiology: An Introduction (13th ed.). Pearson.
D311 Final Exam: Key Study Questions on Microbial Pathogenesis
Murray, P. R., Rosenthal, K. S., & Pfaller, M. A. (2019). Medical Microbiology (9th ed.). Elsevier.
Ryan, K. J., & Ray, C. G. (2017). Sherris Medical Microbiology (6th ed.). McGraw-Hill.